In this study, we found that METTL14 may inhibit the progression of hepatocellular carcinoma (HCC) by up‐regulating the expression levels of cysteine sulfinic acid decarboxylase, glutamic‐oxaloacetic transaminase 2, and suppressor of cytokine signaling 2. Here, CSAD is linked to hepatocellular carcinoma.